These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8529170

  • 1. Nerve microvessel changes in diabetes are prevented by aldose reductase inhibition.
    Benstead TJ, Sangalang VE.
    Can J Neurol Sci; 1995 Aug; 22(3):192-7. PubMed ID: 8529170
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE, Cotter MA, Basso M, Hohman TC.
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [Abstract] [Full Text] [Related]

  • 3. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Mar; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 4. Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor.
    Sima AA, Nathaniel V, Prashar A, Bril V, Greene DA.
    Diabetes; 1991 Sep; 40(9):1090-9. PubMed ID: 1936616
    [Abstract] [Full Text] [Related]

  • 5. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
    Cameron NE, Cotter MA, Dines KC, Maxfield EK, Carey F, Mirrlees DJ.
    Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S, Kamijo M, Ido Y, Mirrlees DJ.
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [Abstract] [Full Text] [Related]

  • 7. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ.
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [Abstract] [Full Text] [Related]

  • 8. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L, Day N, Peterson RG, Eichberg J.
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [Abstract] [Full Text] [Related]

  • 9. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 10. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB, Calcutt NA, Compton AM, Tomlinson DR, Keen P.
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [Abstract] [Full Text] [Related]

  • 11. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.
    Yagihashi S, Yamagishi SI, Wada Ri R, Baba M, Hohman TC, Yabe-Nishimura C, Kokai Y.
    Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599
    [Abstract] [Full Text] [Related]

  • 12. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 13. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
    Calcutt NA, Freshwater JD, Mizisin AP.
    Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
    [Abstract] [Full Text] [Related]

  • 14. Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat.
    Kihara M, Mitsui Y, Shioyama M, Hasegawa T, Takahashi M, Takakura S, Minoura K, Kawamura I.
    Neurosci Lett; 2001 Sep 14; 310(2-3):81-4. PubMed ID: 11585572
    [Abstract] [Full Text] [Related]

  • 15. Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats.
    Yasuda H, Terada M, Taniguchi Y, Sasaki T, Maeda K, Haneda M, Kashiwagi A, Kikkawa R.
    Neuroreport; 1999 Aug 02; 10(11):2405-9. PubMed ID: 10439472
    [Abstract] [Full Text] [Related]

  • 16. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB, Calcutt NA, Tomlinson DR.
    Diabetologia; 1987 Apr 02; 30(4):239-43. PubMed ID: 2439402
    [Abstract] [Full Text] [Related]

  • 17. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS, Hohman TC, Millen J.
    J Med Chem; 1994 Jun 24; 37(13):2043-58. PubMed ID: 8027986
    [Abstract] [Full Text] [Related]

  • 18. Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition.
    Mizisin AP, Kalichman MW, Calcutt NA, Myers RR, Powell HC.
    J Neurol Sci; 1993 May 24; 116(1):67-72. PubMed ID: 8389817
    [Abstract] [Full Text] [Related]

  • 19. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T, Nakamura J, Koh N, Sakakibara F, Hamada Y, Sasaki H, Naruse K, Nakashima E, Takeuchi N, Inukai S.
    J Lab Clin Med; 1995 Dec 24; 126(6):541-7. PubMed ID: 7490513
    [Abstract] [Full Text] [Related]

  • 20. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA.
    Diabet Med; 1998 Jul 24; 15(7):579-85. PubMed ID: 9686698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.